US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine
As fears of a pandemic mount, the biotech company’s mRNA vaccine trial is set to release Phase 1/2 results later this year, with a larger Phase 3 trial expected to begin in 2025.
![US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine](https://media.wired.com/photos/6685bc4d8e2618989e172ed8/191:100/w_1280,c_limit/US-Government-Awards-Moderna-$176-Million-for-mRNA-Bird-Flu-Vaccine-GettyImages-2151865875.jpg)
What's Your Reaction?
![like](https://www.nimedy.com/assets/img/reactions/like.png)
![dislike](https://www.nimedy.com/assets/img/reactions/dislike.png)
![love](https://www.nimedy.com/assets/img/reactions/love.png)
![funny](https://www.nimedy.com/assets/img/reactions/funny.png)
![angry](https://www.nimedy.com/assets/img/reactions/angry.png)
![sad](https://www.nimedy.com/assets/img/reactions/sad.png)
![wow](https://www.nimedy.com/assets/img/reactions/wow.png)